Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.24.2.u1
Condensed Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 41,409 $ 50,501
Accounts receivable 1,358 926
Contract assets and unbilled receivables 948 1,407
Prepaids and other assets 1,114 1,099
Short-term investments 5 15
Total current assets 44,834 53,948
Property and equipment, net 0 0
Total assets 44,834 53,948
Current liabilities:    
Accounts payable 634 2,153
Accrued expenses 3,490 1,815
Derivative liability 74 74
Total current liabilities 4,198 4,042
Total liabilities 4,198 4,042
Commitments and contingencies (Note 3 and Note 8)
Stockholders' equity:    
Preferred stock, par value $0.0001; 10,000,000 shares authorized as of June 30, 2024 and December 31, 2023; no shares issued and outstanding at June 30, 2024 and December 31, 2023. 0 0
Common stock, par value $0.0001; 125,000,000 and 75,000,000 shares authorized as of June 30, 2024 and December 31, 2023, respectively; 25,979,038 and 23,977,491 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively. 3 2
Additional paid-in capital 136,970 131,370
Accumulated deficit (96,337) (81,466)
Total stockholders' equity 40,636 49,906
Total liabilities and stockholders' equity $ 44,834 $ 53,948